Correlation Between Unicycive Therapeutics and Assembly Biosciences
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Assembly Biosciences, you can compare the effects of market volatilities on Unicycive Therapeutics and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Assembly Biosciences.
Diversification Opportunities for Unicycive Therapeutics and Assembly Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Assembly is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Assembly Biosciences go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Assembly Biosciences
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.06 times less return on investment than Assembly Biosciences. In addition to that, Unicycive Therapeutics is 1.9 times more volatile than Assembly Biosciences. It trades about 0.04 of its total potential returns per unit of risk. Assembly Biosciences is currently generating about 0.09 per unit of volatility. If you would invest 891.00 in Assembly Biosciences on September 2, 2024 and sell it today you would earn a total of 813.00 from holding Assembly Biosciences or generate 91.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Assembly Biosciences
Performance |
| Timeline |
| Unicycive Therapeutics |
| Assembly Biosciences |
Unicycive Therapeutics and Assembly Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Assembly Biosciences
The main advantage of trading using opposite Unicycive Therapeutics and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |